Biocorrx (OTCMKTS:BICX) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Biocorrx (OTCMKTS:BICX) posted its quarterly earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03, Zacks reports.

Biocorrx Stock Performance

Shares of BICX traded up $0.09 during trading hours on Friday, hitting $0.49. The company had a trading volume of 27,821 shares, compared to its average volume of 7,777. Biocorrx has a 52-week low of $0.20 and a 52-week high of $1.28. The firm has a fifty day moving average price of $0.37 and a 200-day moving average price of $0.35. The stock has a market capitalization of $14.36 million, a price-to-earnings ratio of -2.60 and a beta of 0.17.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.